The average one-year price target for Veru (NasdaqCM:VERU) has been revised to $25.50 / share. This is an increase of 11.11% from the prior estimate of $22.95 dated January 11, 2026. The price target ...

As of December 6, 2025, the average one-year price target for Veru is $21.68/share. The forecasts range from a low of $10.10 to a high of $31.50. The average price target represents an increase of 850 ...

Image source: The Motley Fool. Veru (NASDAQ:VERU) presented new regulatory feedback confirming potential U.S. approval paths for Novosarm-GLP-1 combination therapy based on either incremental weight ...

Veru Inc. beats earnings expectations. Reported EPS is $-0.26254, expectations were $-0.47. Operator: Good morning, ladies and gentlemen, and welcome to Veru Inc. Investors Conference Call. All ...